Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinitis pigmentosa.

Christian Hamel1

  • 1Inserm U, 583, Physiopathologie et thérapie des déficits sensoriels et moteurs, Institut des Neurosciences de Montpellier, Hôpital Saint-Eloi, BP 74103, 80 av, Augustin Fliche, 34091 Montpellier Cedex 05, France. hamel@montp.inserm.fr

Orphanet Journal of Rare Diseases
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of the early pupillary dilation kinetic to assess rod and cone activity.

Scientific reports·2021
Same author

Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy.

The Journal of clinical investigation·2019
Same author

Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04).

Annals of surgical oncology·2019
Same author

Natural models for retinitis pigmentosa: progressive retinal atrophy in dog breeds.

Human genetics·2019
Same author

Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain.

Clinical chemistry·2018
Same author

Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the <i>TYR</i> gene.

The British journal of ophthalmology·2018
Same journal

A lifespan pooled analysis of 832 cases: characterizing the lifespan profile of clinical presentations and comorbidities in congenital pulmonary airway malformation.

Orphanet journal of rare diseases·2026
Same journal

Mortality trends and socioeconomic inequalities in sickle cell disease in Colombia, 2012-2023: a population-based study.

Orphanet journal of rare diseases·2026
Same journal

Mitochondrial stress markers associate with phenotypic variability in Fabry disease.

Orphanet journal of rare diseases·2026
Same journal

Preclinical modeling of Loeys-Dietz syndrome: insights into mechanisms and therapy.

Orphanet journal of rare diseases·2026
Same journal

Fatigue and pain in children with multiple osteochondromas: a cross-sectional study.

Orphanet journal of rare diseases·2026
Same journal

Health service access and delivery for people living with rare disorders: a scoping review.

Orphanet journal of rare diseases·2026
See all related articles

Retinitis pigmentosa (RP) is an inherited retinal disease causing photoreceptor loss and progressive vision impairment. Current treatments focus on slowing progression and managing complications, with emerging therapies offering future hope.

Area of Science:

  • Ophthalmology
  • Genetics
  • Retinal Diseases

Background:

  • Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterized by progressive photoreceptor degeneration.
  • It affects approximately 1 in 4,000 individuals, leading to night blindness, peripheral vision loss, and eventual blindness.
  • RP can be non-syndromic or part of syndromes like Usher syndrome, with over 45 causative genes identified.

Purpose of the Study:

  • To provide a comprehensive overview of retinitis pigmentosa, including its genetic basis, clinical manifestations, diagnosis, and current management strategies.
  • To highlight the challenges in diagnosis and treatment due to genetic heterogeneity and the lack of curative therapies.
  • To discuss emerging therapeutic avenues for retinitis pigmentosa.

Main Methods:

Related Experiment Videos

  • Review of existing literature on retinitis pigmentosa genetics, clinical presentation, diagnosis, and treatment.
  • Analysis of diagnostic criteria including fundus examination, electroretinography, and genetic testing.
  • Summary of current therapeutic approaches and emerging research in gene therapy, neuroprotection, and retinal prostheses.

Main Results:

  • RP presents as rod-cone or cone-rod dystrophy with varying progression rates.
  • Diagnosis relies on clinical signs, electroretinography, and genetic testing, though the latter is limited by genetic heterogeneity.
  • No current therapy halts RP progression; management focuses on slowing degeneration, treating complications, and supportive care.

Conclusions:

  • Retinitis pigmentosa is a severe inherited condition with significant visual impairment and a poor visual prognosis.
  • Genetic counseling is crucial due to the wide range of causative genes.
  • Intensive research into novel therapies like gene therapy and retinal prostheses offers hope for future treatment of RP.